Does SIMVASTATIN Cause Electrocardiogram qt prolonged? 93 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 93 reports of Electrocardiogram qt prolonged have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.3% of all adverse event reports for SIMVASTATIN.
93
Reports of Electrocardiogram qt prolonged with SIMVASTATIN
0.3%
of all SIMVASTATIN reports
10
Deaths
47
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From SIMVASTATIN?
Of the 93 reports, 10 (10.8%) resulted in death, 47 (50.5%) required hospitalization, and 20 (21.5%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 93 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which SIMVASTATIN Alternatives Have Lower Electrocardiogram qt prolonged Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS